Skip to main content
SpringerLink
Log in

Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Brief intermittent episodes of ischemia and reperfusion could reduce infarct size, a phenomenon called “postconditioning” at the onset of reperfusion after a prolonged period of ischemia. To investigate whether the opioid receptors and signaling factor JAK-STAT might be responsible for the cardioprotection in ischemic postconditioning, and the possible molecular machinery of cardioprotection. Hundred and twenty healthy New Zealand rabbits were divided into six groups. The myocardial infarct size, cardiac myocyte apoptosis, BCL-2 and P-Stat3 protein expression were tested in the current study. The results suggested that ischemic postconditioning might increase BCL-2 protein expression by activating the opioid receptors and JAK-STAT signaling pathway, and also to reduce ischemia-reperfusion-induced cardiomyocyte apoptosis and to play a key role in myocardial protection. However, further research still needs to be done to unravel the underlying mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Piper HM, Garcia-Dorado D, Ovize MA (1998) Fresh look at reperfusion injury. Cardiovasc Res 38:291–300

    Article  CAS  PubMed  Google Scholar 

  2. Vinten-Johansen J (2004) Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61:481–497

    Article  CAS  PubMed  Google Scholar 

  3. Cohen MV, Downey JM (2001) Ischemic preconditioning: description, mechanism, and significance. In: Sperelakis N, Kurachi Y, Terzic A, Cohen MV (eds) Heart physiology and pathophysiology, 4th edn. Academic Press, San Diego, pp 867–885

    Chapter  Google Scholar 

  4. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, Zhao ZQ, Guyton RA, Headrick JP, Vinten-Johansen J (2005) Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67:124–133

    Article  CAS  PubMed  Google Scholar 

  5. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915–1919

    Article  PubMed  Google Scholar 

  6. Skyschally A, Van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15–18

    Article  CAS  PubMed  Google Scholar 

  7. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV (2004) Multiple brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. Am Coll Cardiol 44:1103–1110

    Article  Google Scholar 

  8. Farb A, Kolodgie FD, Jenkins M, Virmani R (1993) Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 21:1245–1253

    Article  CAS  PubMed  Google Scholar 

  9. Van den Hoek TL, Shao Z, Li C, Zak R, Schumacker PT, Becker LB (1996) Reperfusion injury in cardiac myocytes after simulated ischemia. Am J Physiol 270:H1334–H1341

    Google Scholar 

  10. Matsumura K, Jeremy RW, Schaper J, Becker LC (1998) Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97:795–804

    CAS  PubMed  Google Scholar 

  11. Karaali ZE, Sozen S, Yurdum M, Cacina C, Toptas B, Gok O, Agachan B (2010) Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep. Feb 25. [Epub ahead of print]

  12. Yang J, Zhang XD, Yang J, Ding JW, Liu ZQ, Li SG, Yang R (2010) The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4. Mol Biol Rep. Feb 4. [Epub ahead of print]

  13. Chen LL, Zhu TB, Yin H, Huang J, Wang LS, Cao KJ, Yang ZJ (2009) Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Mol Biol Rep. Nov 12. [Epub ahead of print]

  14. Luan B, Han Y, Zhang X, Kang J, Yan C (2010) Association of the SDF1-3′A polymorphism with susceptibility to myocardial infarction in Chinese Han population. Mol Biol Rep 37(1):399–403

    Article  CAS  PubMed  Google Scholar 

  15. Yao YT, Li LH, Chen L, Wang WP, Li LB, Gao CQ (2009) Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore. Mol Biol Rep. Aug 20. [Epub ahead of print]

  16. Yilmaz E, Akar R, Eker ST, Deda G, Adiguzel Y, Akar N (2010) Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia. Mol Biol Rep 37(1):269–272

    Article  CAS  PubMed  Google Scholar 

  17. Tang J, Wang J, Song H, Huang Y, Yang J, Kong X, Guo L, Zheng F, Zhang L (2010) Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep 37(4):1957–1969

    Article  CAS  PubMed  Google Scholar 

  18. Hou X, Wu X, Ma J, Lv X, Jin X (2010) Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia. Mol Biol Rep 37(3):1467–1475

    Article  CAS  PubMed  Google Scholar 

  19. Ganesan B, Buddhan S, Anandan R, Sivakumar R, AnbinEzhilan R (2010) Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. Mol Biol Rep 37(3):1319–1327

    Article  CAS  PubMed  Google Scholar 

  20. Chen Z, Zhang X, Ma G, Qian Q, Yao Y (2010) Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population. Mol Biol Rep 37(1):207–212

    Article  CAS  PubMed  Google Scholar 

  21. Chen Z, Ma G, Qian Q, Yao Y, Feng Y, Tang C (2009) Toll-like receptor 8 polymorphism and coronary artery disease. Mol Biol Rep 36(7):1897–1901

    Article  CAS  PubMed  Google Scholar 

  22. Chen Z, Qian Q, Ma G, Wang J, Zhang X, Feng Y, Shen C, Yao Y (2009) A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep 36(5):889–893

    Article  CAS  PubMed  Google Scholar 

  23. Liu B, Li W, Li Y, Wang Z, Li H, Liu P, Fu J (2009) Protective effects of N-acetylcysteine in isoproterenol-induced myocardium injury in rats. Mol Biol Rep 36(4):761–765

    Article  PubMed  Google Scholar 

  24. Ni Y, Zhang J (2009) Association of deoxyribonuclease I genetic polymorphisms with myocardial infarction in Han Chinese. Mol Biol Rep 36(3):595–601

    Article  CAS  PubMed  Google Scholar 

  25. Wan J, Xiong C, Zheng F, Zhou X, Huang C, Jiang H (2008) Study of Kir6.2/KCNJ11 gene in a sudden cardiac death pedigree. Mol Biol Rep 35(2):119–123

    Article  CAS  PubMed  Google Scholar 

  26. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA et al (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285:H579–H588

    CAS  Google Scholar 

  27. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Vinten-Johansen J (2006) Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signaling. Cardiovasc Res 70:315–324

    Article  CAS  PubMed  Google Scholar 

  28. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J (2004) Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62:74–85

    Article  CAS  PubMed  Google Scholar 

  29. Halkos ME, Kerendi F, Corvera JS, Wang NP, Kin H, Payne CS, Sun HY, Guyton RA, Vinten-Johansen J, Zhao ZQ (2004) Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78:961–969

    Article  PubMed  Google Scholar 

  30. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ (2005) Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting the generation of reactive oxygen species and intracellular calcium overload. Am J Physiol Heart Circ Physiol 288:H1900–H1908

    Article  CAS  PubMed  Google Scholar 

  31. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM (2004) Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95:230–232

    Article  CAS  PubMed  Google Scholar 

  32. Yang XM, Krieg T, Cui L, Downey JM, Cohen MV (2004) NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3 K, ERK, and NO. J Mol Cell Cardiol 36:411–421

    Article  CAS  PubMed  Google Scholar 

  33. Bell RM, Yellon DM (2003) Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3 K, Akt and eNOS. J Mol Cell Cardiol 35:185–193

    Article  CAS  PubMed  Google Scholar 

  34. Liao Z, Brar BK, Cai Q, Stephanou A, O′Leary RM, Pennica D, Yellon DM, Latchman DS (2002) Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischemia and at reperfusion. Cardiovasc Res 53:902–910

    Article  CAS  PubMed  Google Scholar 

  35. Jonassen AK, Sack MN, Mjøs OD, Yellon DM (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191–1198

    Article  CAS  PubMed  Google Scholar 

  36. Baxter GF, Mocanu MM, Brar BK, Latchman DS, Yellon DM (2001) Cardioprotective effects of transforming growth factor-beta 1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 38:930–939

    Article  CAS  PubMed  Google Scholar 

  37. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111:194–197

    Article  CAS  PubMed  Google Scholar 

  38. Argaud L, Prigent AF, Chalabreysse L, Loufouat J, Lagarde M, Ovize M (2004) Ceramide in the antiapoptotic effect of ischemic preconditioning. Am J Physiol 286:H246–H251

    CAS  Google Scholar 

  39. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136

    CAS  PubMed  Google Scholar 

  40. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70:308–314

    Article  CAS  PubMed  Google Scholar 

  41. Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76:1713–1719

    Article  CAS  PubMed  Google Scholar 

  42. Zhao ZQ, Sun HY, Wang NP, Kerendi F, Guyton RA, Vinten-Johansen J (2003) Hypoxic post-conditioning reduces cardiomyocyte loss by inhibiting reactive oxygen species-triggered mitochondrial calcium overload. Circulation 108(suppl IV):174

    Google Scholar 

  43. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104:469–483

    Article  PubMed  Google Scholar 

  44. Bolli R, Dawn B, Xuan YT (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc 13:72–79

    Article  CAS  Google Scholar 

  45. Gross ER, Hsu AK, Gross GJ (2006) The JAK-STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol 291:H827–H834

    Article  CAS  PubMed  Google Scholar 

  46. Booz GW, Day JN, Baker KM (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34:1443–1453

    Article  CAS  PubMed  Google Scholar 

  47. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T, Yamauchi-Takihara K (2000) Activation of JAK-STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 47:797–805

    Article  CAS  PubMed  Google Scholar 

  48. Schwarze MM, Hawley RG (1995) Prevention of myeloma cell apoptosis by ectopic BCL-2 expression or interleukin 6-mediated up-regulation of BCL-xL. Cancer Res 55:2262–2265

    CAS  PubMed  Google Scholar 

  49. Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, Okabe M, Kishimoto T, Yamauchi-Takihara K (2000) Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 4:315–319

    Article  Google Scholar 

  50. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK (2001) Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 33:1929–1936

    Article  CAS  PubMed  Google Scholar 

  51. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135

    Article  CAS  PubMed  Google Scholar 

  52. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008) The myocardial JAK-STAT pathway: from protection to failure. Pharmacol Ther 120:172–185

    Article  CAS  PubMed  Google Scholar 

  53. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z (2008) Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology 108:243–250

    Article  CAS  PubMed  Google Scholar 

  54. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J (2008) Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294:H1444–H1451

    Article  CAS  PubMed  Google Scholar 

  55. Mayfield KP, D′Alecy LG (1994) Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 268:74–77

    CAS  PubMed  Google Scholar 

  56. Chien S, Oeltgen PR, Diana JN, Salley RK (1994) Extension of tissue survival time in multiorgan block preparation with a delta opioid DADLE [(D-Ala2, D-Leu5)-enkephalin). J Thorac Cardiovasc Surg 107:964–967

    CAS  PubMed  Google Scholar 

  57. Schultz JE, Hsu AK, Gross GJ (1996) Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78:1100–1104

    CAS  PubMed  Google Scholar 

  58. Peart JN, Gross ER, Reichelt ME, Hsu A, Headrick JP, Gross GJ (2008) Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol 103:454–463

    Article  CAS  PubMed  Google Scholar 

  59. Schultz JJ, Rose E, Yao Z, Gross GJ (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268:H2157–H2161

    CAS  PubMed  Google Scholar 

  60. Chien GL, Tang Y, Van Winkle DM (1995) Stereospecific blockade of myocardial ischemic preconditioning by naloxone. Circulation 92(suppl 8):381–389

    Google Scholar 

  61. Haunstetter A, Izumo S (1998) Apoptosis basic mechanisms and implications for cardio via secular Disease. Circ Res 82:1111–1129

    CAS  PubMed  Google Scholar 

  62. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F (2005) Postconditioning–A new link in nature′s armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100:295–310

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular, Affiliated Zhong-Nan Hospital of Wuhan University, Wuhan, 430072, China

    Lu You & Jianghua Ren

  2. Department of Physiology, Mu-Dan-Jiang Medical College, Heilongjiang, 157011, China

    Li Li & Qiuling Xu

  3. Department of Cardiovascular, Beijing Chao-Yang Hospital, Beijing, 100020, China

    Fan Zhang

Authors
  1. Lu You
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiuling Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianghua Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jianghua Ren or Fan Zhang.

Additional information

L. You, L. Li are Co-first Author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

You, L., Li, L., Xu, Q. et al. Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway. Mol Biol Rep 38, 437–443 (2011). https://doi.org/10.1007/s11033-010-0126-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0126-y

Keywords

Search

Navigation